UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 39

Sortiert nach

Histologic Inflammation Is a Risk Factor for Progression to Colorectal Neoplasia in Ulcerative Colitis: A Cohort Study

Gastroenterology (New York, N.Y. 1943), 2007-10, Vol.133 (4), p.1099-1105

2007

Link zum Volltext

Verfügbarkeit prüfen

The First Endoscopy in Suspected Inflammatory Bowel Disease

Gastrointestinal endoscopy clinics of North America, 2016-10, Vol.26 (4), p.593-610

2016

Link zum Volltext

Verfügbarkeit prüfen

Visible dysplasia: what you see is most of what you get

Gastrointestinal endoscopy, 2007-06, Vol.65 (7), p.1005-1006

Kornbluth, Asher, MD

2007

Link zum Volltext

Verfügbarkeit prüfen

Patients Enrolled in Randomized Controlled Trials Do Not Represent the Inflammatory Bowel Disease Patient Population

Clinical gastroenterology and hepatology, 2012-09, Vol.10 (9), p.1002-1007

2012

Link zum Volltext

Verfügbarkeit prüfen

COVID-19 INFECTIONS IN VACCINATED PATIENTS WITH INFLAMMATORY BOWEL DISEASE: OUTCOMES AND RISK FACTORS FOR SEVERE DISEASE

Gastroenterology (New York, N.Y. 1943), 2022-02, Vol.162 (3), p.S104-S105

2022

Link zum Volltext

Verfügbarkeit prüfen

Su1493: COVID-19 RELATED THROMBOTIC, CARDIOVASCULAR, AND RENAL COMPLICATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA FROM AN INTERNATIONAL REGISTRY

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-599-S-599

2022

Link zum Volltext

Verfügbarkeit prüfen

Longitudinal Changes in Fecal Calprotectin Levels Among Pregnant Women With and Without Inflammatory Bowel Disease and Their Babies

Gastroenterology (New York, N.Y. 1943), 2021-03, Vol.160 (4), p.1118-1130.e3

2021

Link zum Volltext

Verfügbarkeit prüfen

Cyclosporine and Infliximab as Rescue Therapy for Each Other in Patients With Steroid-Refractory Ulcerative Colitis

Clinical gastroenterology and hepatology, 2008-10, Vol.6 (10), p.1112-1116

2008

Link zum Volltext

Verfügbarkeit prüfen

Validation of Endoscopic Activity Scores in Patients With Crohn's Disease Based on a Post Hoc Analysis of Data From SONIC

Gastroenterology (New York, N.Y. 1943), 2013-11, Vol.145 (5), p.978-986.e5

2013

Link zum Volltext

Verfügbarkeit prüfen

Factors Associated With Short- and Long-Term Outcomes of Therapy for Crohn’s Disease

Clinical gastroenterology and hepatology, 2015-03, Vol.13 (3), p.539-547.e2

2015

Link zum Volltext

Verfügbarkeit prüfen

Su1556: MATERNAL INFLAMMATORY BOWEL DISEASE DIAGNOSIS BUT NOT GENETIC DETERMINANTS OF THE DISEASE RISK PREDICT FECAL CALPROTECTIN LEVELS DURING EARLY LIFE

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-629-S-629

2022

Link zum Volltext

Verfügbarkeit prüfen

Progression to Colorectal Neoplasia in Ulcerative Colitis: Effect of Mesalamine

Clinical gastroenterology and hepatology, 2008-11, Vol.6 (11), p.1225-1230

2008

Link zum Volltext

Verfügbarkeit prüfen

Guidance for Restarting Inflammatory Bowel Disease Therapy in Patients Who Withheld Immunosuppressant Medications During COVID-19

Journal of Crohn's & colitis, 2020-10, Vol.14 (Supplement_3), p.S769-S773

2020

Link zum Volltext

Verfügbarkeit prüfen

164 - Vedolizumab Therapy Induces a Redistribution of CD4+ T Cells to Uninvolved Intestinal Mucosa in Patients with Inflammatory Bowel Disease

Gastroenterology (New York, N.Y. 1943), 2018-05, Vol.154 (6), p.S-46-S-46

2018

Link zum Volltext

Verfügbarkeit prüfen

Mo1832 - Baseline Level of Integrin A4B7 on Circulating Plasmablasts Predicts Response to Vedolizumab in Patients with Inflammatory Bowel Disease

Gastroenterology (New York, N.Y. 1943), 2018-05, Vol.154 (6), p.S-818-S-818

2018

Link zum Volltext

Verfügbarkeit prüfen

1062 - Infants Born to Mothers with Inflammatory Bowel Disease Exhibit Distinct Microbiome Features that Persist Up to 3 Months of Life

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S193-S193

2017

Link zum Volltext

Verfügbarkeit prüfen

Infants Born to Mothers with Inflammatory Bowel Disease Exhibit Distinct Microbiome Features that Persist Up to 3 Months of Life

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S193-S193

2017

Link zum Volltext

Verfügbarkeit prüfen

Su1907 Exploring MEChanisms of IBD traNsmission In Utero through the Microbiome: The MECONIUM Study Pilot

Gastroenterology (New York, N.Y. 1943), 2016-04, Vol.150 (4), p.S585-S585

2016

Link zum Volltext

Verfügbarkeit prüfen

Sa1202 Relationships Between Clinical Remission, C-Reactive Protein Normalization and Mucosal Healing in Crohn's Disease: Analyses From the SONIC trial

Gastroenterology (New York, N.Y. 1943), 2013-05, Vol.144 (5), p.S-228-S-228

2013

Link zum Volltext

Verfügbarkeit prüfen

Are Patients Enrolled in Randomized Controlled Trials (RCTs) Representative of the General Inflammatory Bowel Disease (IBD) Patient Population?

Gastroenterology (New York, N.Y. 1943), 2011, Vol.140 (5), p.S-113-S-113

2011

Link zum Volltext

Verfügbarkeit prüfen

T1332 Clinical Presentation, Outcome and Survival of Ulcerative Colitis Patients Admitted to an Intensive Care Unit

Gastroenterology (New York, N.Y. 1943), 2010, Vol.138 (5), p.S-539-S-539

2010

Link zum Volltext

Verfügbarkeit prüfen

1055 Recommendations for Creating a High Quality Endoscopy Report for Inflammatory Bowel Disease Patients: Results From a RAND-Appropriateness Panel

Gastroenterology (New York, N.Y. 1943), 2014-05, Vol.146 (5), p.S-188-S-188

2014

Link zum Volltext

Verfügbarkeit prüfen

791 Adjustable Intragastric Balloons: A 12 Month Pilot Trial in Endoscopic Weight Loss Management

Gastrointestinal endoscopy, 2011-04, Vol.73 (4), p.AB151-AB151

2011

Link zum Volltext

Verfügbarkeit prüfen

M1507: A Novel Adjustable Intragastric Balloon (IGB) to Treat Obesity: A Pilot Study

Gastrointestinal endoscopy, 2010-04, Vol.71 (5), p.AB240-AB240

2010

Link zum Volltext

Verfügbarkeit prüfen

Association of Steroid-Free Clinical Remission and Complete Mucosal Healing at 6 Months With Clinical Outcome at 1 Year: A Post-Hoc Analysis of SONIC trial Data

Gastroenterology (New York, N.Y. 1943), 2011, Vol.140 (5), p.S-261-S-262

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 39

Suche als RSS-Feed

Aktive Filter

KollektionElsevier ScienceDirect Journals Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(39)

Sprache

Englisch
(39)
Japanisch
(3)

Erscheinungsjahr

n.n

Kollektion

3 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

2 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Histologic Inflammation Is a Risk Factor for Progression to Colorectal Neoplasia in Ulcerative Colitis: A Cohort Study

The First Endoscopy in Suspected Inflammatory Bowel Disease

Visible dysplasia: what you see is most of what you get

Patients Enrolled in Randomized Controlled Trials Do Not Represent the Inflammatory Bowel Disease Patient Population

COVID-19 INFECTIONS IN VACCINATED PATIENTS WITH INFLAMMATORY BOWEL DISEASE: OUTCOMES AND RISK FACTORS FOR SEVERE DISEASE

Su1493: COVID-19 RELATED THROMBOTIC, CARDIOVASCULAR, AND RENAL COMPLICATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA FROM AN INTERNATIONAL REGISTRY

Longitudinal Changes in Fecal Calprotectin Levels Among Pregnant Women With and Without Inflammatory Bowel Disease and Their Babies

Cyclosporine and Infliximab as Rescue Therapy for Each Other in Patients With Steroid-Refractory Ulcerative Colitis

Validation of Endoscopic Activity Scores in Patients With Crohn's Disease Based on a Post Hoc Analysis of Data From SONIC

Factors Associated With Short- and Long-Term Outcomes of Therapy for Crohn’s Disease

Su1556: MATERNAL INFLAMMATORY BOWEL DISEASE DIAGNOSIS BUT NOT GENETIC DETERMINANTS OF THE DISEASE RISK PREDICT FECAL CALPROTECTIN LEVELS DURING EARLY LIFE

Progression to Colorectal Neoplasia in Ulcerative Colitis: Effect of Mesalamine

Guidance for Restarting Inflammatory Bowel Disease Therapy in Patients Who Withheld Immunosuppressant Medications During COVID-19

164 - Vedolizumab Therapy Induces a Redistribution of CD4+ T Cells to Uninvolved Intestinal Mucosa in Patients with Inflammatory Bowel Disease

Mo1832 - Baseline Level of Integrin A4B7 on Circulating Plasmablasts Predicts Response to Vedolizumab in Patients with Inflammatory Bowel Disease

1062 - Infants Born to Mothers with Inflammatory Bowel Disease Exhibit Distinct Microbiome Features that Persist Up to 3 Months of Life

Infants Born to Mothers with Inflammatory Bowel Disease Exhibit Distinct Microbiome Features that Persist Up to 3 Months of Life

Su1907 Exploring MEChanisms of IBD traNsmission In Utero through the Microbiome: The MECONIUM Study Pilot

Sa1202 Relationships Between Clinical Remission, C-Reactive Protein Normalization and Mucosal Healing in Crohn's Disease: Analyses From the SONIC trial

Are Patients Enrolled in Randomized Controlled Trials (RCTs) Representative of the General Inflammatory Bowel Disease (IBD) Patient Population?

T1332 Clinical Presentation, Outcome and Survival of Ulcerative Colitis Patients Admitted to an Intensive Care Unit

1055 Recommendations for Creating a High Quality Endoscopy Report for Inflammatory Bowel Disease Patients: Results From a RAND-Appropriateness Panel

791 Adjustable Intragastric Balloons: A 12 Month Pilot Trial in Endoscopic Weight Loss Management

M1507: A Novel Adjustable Intragastric Balloon (IGB) to Treat Obesity: A Pilot Study

Association of Steroid-Free Clinical Remission and Complete Mucosal Healing at 6 Months With Clinical Outcome at 1 Year: A Post-Hoc Analysis of SONIC trial Data

Aktive Filter

Suchergebnisse filtern